Fadi Braiteh

Fadi Braiteh

UNVERIFIED PROFILE

Are you Fadi Braiteh?   Register this Author

Register author
Fadi Braiteh

Fadi Braiteh

Publications by authors named "Fadi Braiteh"

Are you Fadi Braiteh?   Register this Author

60Publications

1757Reads

38Profile Views

Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer.

Lung Cancer 2019 Sep 21;135:104-109. Epub 2019 May 21.

David Geffen School of Medicine at University of California Los Angeles, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.022DOI Listing
September 2019

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.

J Clin Oncol 2018 02 12;36(4):359-366. Epub 2017 Dec 12.

Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.9564
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.9564DOI Listing
February 2018

Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors.

Oncology 2016 7;91(5):251-260. Epub 2016 Sep 7.

START Madrid, Centro Integral Oncológico Clara Campal, Madrid Norte Sanchinarro University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000448621DOI Listing
January 2017

Cases in the Management of GEP-NETs: Combination Regimens.

Authors:
Fadi Braiteh

Clin Adv Hematol Oncol 2016 Apr;14(4 Suppl 6):11-3

University of Nevada School of Medicine, Las Vegas, Nevada.

View Article

Download full-text PDF

Source
April 2016

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

Lancet 2016 Feb 29;387(10018):545-557. Epub 2015 Nov 29.

National Institute of Cancer Research, National Health Research Institutes, Tainan, and Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361500986
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(15)00986-1DOI Listing
February 2016

Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI.

Lung Cancer 2015 Sep 29;89(3):357-9. Epub 2015 Jun 29.

Division of Hematology-Oncology, Department of Medicine, Chao Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA 92868, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.06.021DOI Listing
September 2015

Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.

Oncologist 2015 May 16;20(5):499-507. Epub 2015 Apr 16.

Foundation Medicine Inc., Cambridge, Massachusetts, USA; Chao Family Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, California, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; University of Chicago, Chicago, Illinois, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, USA; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425384PMC
May 2015

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.

Nature 2014 Nov;515(7528):558-62

University of Nevada School of Medicine and US Oncology/Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13904DOI Listing
November 2014

Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management.

Cancer Manag Res 2014 4;6:93-103. Epub 2014 Mar 4.

Innovative Medical Research of South Florida, Inc, Aventura, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S52217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949557PMC
June 2014

Reply to P.A. Beatty et al.

Authors:
Fadi Braiteh

J Clin Oncol 2013 Jul;31(21):2752

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.4419DOI Listing
July 2013

Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial.

J Clin Oncol 2009 Dec 13;27(36):6243-50. Epub 2009 Oct 13.

The University of Texas M. D. Anderson Cancer Center, Department of Investigational Cancer Therapeutics, Unit 455, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.23.6018
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.23.6018DOI Listing
December 2009

Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy.

Cancer 2009 Oct;115(19):4450-8

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24488DOI Listing
October 2009

Spontaneous haemopericardium with subacute cardiac tamponade in a patient with lung cancer receiving coumadin.

QJM 2009 Aug 7;102(8):575. Epub 2009 Feb 7.

Division of Cancer Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/qjmed/hcp009DOI Listing
August 2009

Electronic clinical challenges and images in GI. Image 2. Extensive bilateral extracranial subcutaneous fluid collection.

Gastroenterology 2009 Jun 8;136(7):e3-6. Epub 2009 May 8.

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.11.013DOI Listing
June 2009

Pneumopericardium.

CMAJ 2008 Nov;179(10):1087

Division of Cancer Medicine and Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.080707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572672PMC
November 2008

Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.

Clin Cancer Res 2008 Oct;14(19):6296-301

Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine and Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582814PMC
October 2008

Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma.

J Clin Oncol 2008 Sep;26(27):4511-3

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences, University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.6560DOI Listing
September 2008

Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.

J Clin Oncol 2008 Jul;26(20):3460-2

Department of Investigational Cancer Therapeutics, Phase I Program, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.16.9391DOI Listing
July 2008

Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center.

J Palliat Med 2007 Oct;10(5):1146-52

Department of Palliative Care and Rehabilitation Medicine, Section of Symptom Control and Palliative Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.cccnevada.com/wp-content/uploads/Braiteh-Predicto
Web Search
http://www.liebertonline.com/doi/abs/10.1089/jpm.2006.0259
Publisher Site
http://dx.doi.org/10.1089/jpm.2006.0259DOI Listing
October 2007

Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center.

J Palliat Med 2007 Aug;10(4):948-55

Department of Palliative Care and Rehabilitation Medicine, The University of Texas-M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jpm.2006.0257DOI Listing
August 2007

Uncommon tumors and exceptional therapies: paradox or paradigm?

Mol Cancer Ther 2007 Apr;6(4):1175-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-06-0674DOI Listing
April 2007

Feeling bloated.

Am J Emerg Med 2007 Feb;25(2):207-8

Division of Cancer Medicine, Section of General Internal Medicine, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07356757060030
Publisher Site
http://dx.doi.org/10.1016/j.ajem.2006.10.001DOI Listing
February 2007

Cryptogenic invasive Klebsiella pneumoniae liver abscess syndrome.

Int J Infect Dis 2007 Jan 10;11(1):16-22. Epub 2006 Feb 10.

Phase I Program, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 422, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S120197120500209
Publisher Site
http://dx.doi.org/10.1016/j.ijid.2005.10.006DOI Listing
January 2007

CAT scan reveals BAT sign.

Lancet 2007 Jan;369(9557):217

Phase I Program, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(07)60110-XDOI Listing
January 2007

"I have bad news ... you've got cancer".

Authors:
Fadi Braiteh

J Natl Med Assoc 2006 Nov;98(11):1882-3

Hematology and Medical Oncology Fellowship Program, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569792PMC
November 2006

Computed axial tomography scanning (CT scan).

Clin Anat 2006 Oct;19(7):682-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ca.20356DOI Listing
October 2006

Hemiparesis following sunbathing.

Am J Emerg Med 2006 May;24(3):380-2

Phase I Program, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajem.2005.11.008DOI Listing
May 2006

CASE 1. Langerhans cell histiocytosis of the thyroid.

J Clin Oncol 2006 Jan;24(3):522-3

Phase I Program, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.3763DOI Listing
January 2006

Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha.

Blood 2005 Nov 14;106(9):2992-4. Epub 2005 Jul 14.

Phase I Program, Division of Cancer Medicine and University of Texas Graduate School of Biomedical Sciences at Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-06-2238DOI Listing
November 2005

Transient pneumobilia following upper gastrointestinal endoscopy.

Am J Gastroenterol 2005 Oct;100(10):2364-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2005.50650_4.xDOI Listing
October 2005

Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.

Cancer 2005 Sep;104(6):1322-31

Division of Cancer Medicine, Phase I Program and Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, 77230, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21300
Publisher Site
http://dx.doi.org/10.1002/cncr.21300DOI Listing
September 2005

Pain and terminal delirium research in the elderly.

Clin Geriatr Med 2005 Feb;21(1):93-119, viii

Department of Symptom Control and Palliative Care, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 8, Houston, TX 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cger.2004.09.002DOI Listing
February 2005